CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes

Vaccine

Volumn 30, Issue 6, 2012, Pages 1181-1190

  Singh, Rajesh ^a   Singh, Shailesh ^a   Briles, David E ^b   Taub, Dennis D ^c   Hollingshead, Susan K ^b   Lillard, James W ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

HTL epitope; Streptococcus pneumoniae; T helper cytokine

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCL5; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; MEMBRANE PROTEIN; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

ANIMALS; BACTERIAL PROTEINS; CHEMOKINE CCL5; EPITOPES; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84856314662     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.020     Document Type: Article

References (48)

1. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 2009, 3:16-20.
2. Dagan R., Givon-Lavi N., Leibovitz E., Greenberg D., Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009, 199:776-785.
3. Reinert R.R. The public health ramifications of pneumococcal resistance. Clin Microbiol Infect 2009, 3:1-3.
4. Katsarolis I., Poulakou G., Analitis A., Matthaiopoulou I., Roilides E., Antachopoulos C., et al. Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece. BMC Infect Dis 2009, 9:120.
5. Lillard J.W., Boyaka P.N., Hedrick J.A., Zlotnik A., McGhee J.R. Lymphotactin acts as an innate mucosal adjuvant. J Immunol 1999, 162:1959-1965.
6. Lillard J.W., Boyaka P.N., Taub D.D., McGhee J.R. RANTES potentiates antigen-specific mucosal immune responses. J Immunol 2001, 166:162-169.
7. Lillard J.W., Singh U.P., Boyaka P.N., Singh S., Taub D.D., McGhee J.R. MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood 2003, 101:807-814.
8. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998, 19(12):568-574.
9. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2001, 2:102-107.
10. Darville T., Andrews C.W., Sikes J.D., Fraley P.L., Braswell L., Rank R.G. Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun 2001, 69:7419-7424.
11. Schrum S., Probst P., Fleischer B., Zipfel P.F. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol 1996, 157:3598-3604.
12. Bonecchi R., Bianchi G., Bordignon P.P., D'ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-134.
13. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997, 277:2005-2007.
14. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol 2001, 22:83-87.
15. Makino Y., Cook D.N., Smithies O., Hwang O.Y., Neilson E.G., Turka L.A., et al. Impaired T cell function in RANTES-deficient mice. Clin Immunol 2002, 102:302-309.
16. Ifere G.O., He Q., Igietseme J.U., Ananaba G.A., Lyn D., Lubitz W., et al. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. J Microbiol Immunol Infect 2007, 40:188-200.
17. Liu H., Chao D., Nakayama E.E., Taguchi H., Goto M., Xin X., et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 1999, 96:4581-4585.
18. McDermott D.H., Beecroft M.J., Kleeberger C.A., Al-Sharif F.M., Ollier W.E., Zimmerman P.A., et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000, 14:2671-2678.
19. Palaniappan R., Singh S., Singh U.P., Singh R., Ades E.W., Briles D.E., et al. CCL5 modulates pneumococcal immunity and carriage. J Immunol 2006, 176:2346-2356.
20. Singh R., Singh S., Sharma P.K., Singh U.P., Briles D.E., Hollingshead S.K., et al. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. PLoS One 2010, 5:e9432.
21. Briles D.E., Hollingshead S.K., Paton J.C., Ades E.W., Novak L., Van Ginkel F.W., et al. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. Infect Immun 2003, 188:339-348.
22. Briles D.E., Crain M.J., Gray B.M., Forman C., Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992, 60:111-116.
23. Aaberge I.S., Eng J., Lermark G., Lovik M. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 1995, 18:141-152.
24. Briles D.E., Ades E., Paton J.C., Sampson J.S., Carlone G.M., Huebner R.C., et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 2000, 68:796-800.
25. Kadioglu A., Gingles N.A., Grattan K., Kerr A., Mitchell T.J., Andrew P.W. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 2000, 68:492-501.
26. Valerio R.M., Benstead M., Bray A.M., Campbell R.A., Maeji N.J. Synthesis of peptide analogues using the multipin peptide synthesis method. Anal Biochem 1991, 197:168-177.
27. Palaniappan R., Singh S., Singh U.P., Sakthivel S.K., Ades E.W., Briles D.E., et al. Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun 2005, 73:1006-1013.
28. Shaper M., Hollingshead S.K., Benjamin W.H., Briles D.E. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect Immun 2004, 72:5031-5040.
29. Alexander J., Sidney J., Southwood S., Ruppert J., Oseroff C., Maewal A., et al. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1994, 1:751-761.
30. Sette A., Buus S., Appella E., Smith J.A., Chesnut R., Miles C., et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A 1989, 86:3296-3300.
31. Koedel U., Bernatowicz A., Frei K., Fontana A., Pfister H.W. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J Immunol 1996, 157:5185-5191.
32. Wang J.F., Park I.W., Groopman J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000, 95:2505-2513.
33. Van der Sluijs K.F., van Elden L.J.R., Nijhuis M., Schuurman R., Pater J.M., Florquin S., et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004, 172:7603-7609.
34. Cousins D.J., Lee T.H., Staynov D.Z. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol 2002, 169:2498-2506.
35. Martin I., Shastri V.P., Padera R.F., Yang J., Mackay A.J., Langer R., et al. Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams. J Biomed Mater Res 2001, 55:229-235.
36. Nixon J.C., Ferrell S., Miner C., Oldham A.L., Hochgeschwender U., Webb C.F. Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells. J Immunol 2008, 181:6913-6922.
37. Chattopadhyay G., Khan A.Q., Sen G., Colino J., DuBois W., Rubtsov A., et al. Transgenic expression of Bcl-xL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae. J Immunol 2007, 179:7523-7534.
38. Zhang S., Cubas R., Li M., Chen C., Yao Q. Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells. Mol Immunol 2009, 46:1988-2001.
39. Hansell C.A., Schiering C., Kinstrie R., Ford L., Bordon Y., McInnes I.B., et al. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 2011, 117:5413-5424.
40. Wong S.C., Puaux A.L., Chittezhath M., Shalova I., Kajiji T.S., Wang X., et al. Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol 2010, 40:2296-2307.
41. Pomeroy C., Rubins J.B. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 1997, 65:2975-2977.
42. Yanagawa Y., Iwabuchi K., Onoe K. Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions. Immunology 2009, 127:345-353.
43. Anonymous. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series, 2000; 894:i-xii, 1-253.
44. Hausmann L.R., Ibrahim S.A., Mehrotra A., Nsa W., Bratzler D.W., Mor M.K., et al. Racial and ethnic disparities in pneumonia treatment and mortality. Med Care 2009, 47:1009-1017.
45. Marrie T.J. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect 1999, 14:227-236.
46. Harrison L.H., Dwyer D.M., Billmann L., Kolczak M.S., Schuchat A. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Arch Intern Med 2000, 160:89-94.
47. McDaniel L.S., Yother J., Vijayakumar M., McGarry L., Guild W.R., Briles D.E. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 1987, 165:381-394.
48. Berry A.M., Yother J., Briles D.E., Hansman D., Paton J.C. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 1989, 57:2037-2042.